
Zoloft is the brand name for sertraline, one of the most widely prescribed SSRIs (selective serotonin reuptake inhibitors) in the United States. It is FDA-approved for major depressive disorder, panic disorder, social anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder, and premenstrual dysphoric disorder. This makes it one of the most versatile psychiatric medications available.
The most frequently reported Zoloft side effects include nausea (most common during the first week, usually subsiding), diarrhea or loose stools (more prevalent with sertraline than other SSRIs), headache, dizziness, insomnia or drowsiness, dry mouth, increased sweating, and sexual dysfunction (decreased libido, delayed orgasm, or erectile difficulties). Gastrointestinal effects are notably more common with Zoloft compared to Lexapro or other SSRIs, but they typically resolve within the first 2-3 weeks.
Among SSRIs, Zoloft has several distinctive characteristics. It has mild dopamine reuptake inhibition (unique among SSRIs), which may contribute to slightly more activating effects compared to purely serotonergic SSRIs. It has one of the most favorable drug interaction profiles among SSRIs because it is a relatively weak inhibitor of liver CYP enzymes. It tends to be more GI-activating (more diarrhea) but less sedating than paroxetine or fluvoxamine. It is considered one of the best-tolerated SSRIs overall and is often a first-line choice.
Zoloft is typically started at 25-50mg daily, with increases of 25-50mg every 1-2 weeks as tolerated. The therapeutic range for most conditions is 50-200mg daily. Starting low (25mg) is especially important for adults with anxiety or panic disorder, as initial SSRI activation can temporarily worsen anxiety. Taking Zoloft with food reduces nausea and improves absorption. Most adults notice initial improvement in anxiety symptoms within 1-2 weeks, with full antidepressant effects developing over 4-8 weeks.
Zoloft should not be stopped abruptly. Discontinuation syndrome can include dizziness, nausea, flu-like symptoms, irritability, insomnia, and electric shock sensations. However, Zoloft's discontinuation syndrome is generally milder than Effexor or paroxetine due to its longer half-life. A gradual taper over 2-4 weeks is typically sufficient. Your psychiatrist will guide the tapering schedule.
Zoloft is generally weight-neutral in the short term. Long-term use (6+ months) may be associated with modest weight gain in some adults, but it is considered one of the least weight-affecting SSRIs. If weight is a primary concern, Wellbutrin (which is weight-neutral to slightly weight-reducing) may be discussed as an alternative or adjunct.
Yes. Zoloft is one of the few medications FDA-approved for multiple anxiety disorders AND depression. This dual efficacy makes it particularly useful when both conditions are present, which is extremely common. A comprehensive psychiatric evaluation helps determine whether Zoloft is the right choice for your specific combination of symptoms.
Another widely prescribed SSRI is fluoxetine. Read about Prozac side effects including its unique long half-life and how it compares to sertraline.
Citalopram is an older SSRI closely related to sertraline. Review citalopram (Celexa) side effects and how it compares to newer options.
For a broader understanding of how this medication class works, see our guide to SSRI side effects and how individual medications compare.
This content is for informational purposes only and should not replace professional medical advice, diagnosis, or treatment. If you have questions about Zoloft, schedule an appointment with Elevate Psychiatry. We serve adults 18 and older through our Miami offices in Coconut Grove and Doral, as well as virtually throughout Florida.